Trial Profile
A Phase I of lirilumab in Elderly Patients with Acute Myeloid Leukaemia in First Complete Remission
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jul 2014
Price :
$35
*
At a glance
- Drugs Lirilumab (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 17 Jul 2014 New trial record